Why Clinicians Should Be Excited About Austedo XR

Rakesh Jain, MD, shares more about the recent approval of Austedo XR for the treatment of tardive dyskinesia and Huntington disease chorea control.

Related Keywords

Texas ,United States ,Americans ,Rakesh Jain ,Texas Tech University School Of Medicine ,Drug Administration ,Teva Pharmaceutical Austedo ,Psychiatric Times ,Texas Tech University School ,